Vimarsana
Biggest News Aggregation in the World

Page 30 - Pharma Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Research Today - Breaking & Trending Today

Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application - Vimarsana News

Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval21-Jun-2022 / 14:30 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Applicati...

Investegate |Relief Therapeutics Holding SA Announcements | Relief Therapeutics Holding SA: Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission - Vimarsana News

Investegate |Relief Therapeutics Holding SA Announcements | Relief Therapeutics Holding SA: Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Investegate announcements from Relief Therapeutics Holding SA, Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission 17-Jun-2022

Adhoc: Relief Therapeutics Holding SA: Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil 13-Jun-2022 /

Adhoc: Relief Therapeutics Holding SA: Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001 - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001